Demant Resultados de beneficios anteriores
Todavía estamos procesando el último informe de beneficios de esta empresa
Pasado controles de criterios 3/6
Demant ha aumentado sus beneficios a una tasa media anual de 13.8%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 5.1% anual. Los ingresos han ido creciendo a una tasa media de 10.4% al año. La rentabilidad financiera de Demant es de 27.4%, y sus márgenes netos son de 11.4%.
Información clave
13.8%
Tasa de crecimiento de los beneficios
16.1%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | -1.7% |
| Tasa de crecimiento de los ingresos | 10.4% |
| Rentabilidad financiera | 27.4% |
| Margen neto | 11.4% |
| Próxima actualización de resultados | 14 Aug 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)
Apr 26
Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Mar 18Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal
Mar 06Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching
Feb 22Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet
Feb 08Demant A/S (CPH:DEMANT) Not Flying Under The Radar
Jan 22A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jan 04At kr.302, Is Demant A/S (CPH:DEMANT) Worth Looking At Closely?
Dec 17Some Investors May Be Worried About Demant's (CPH:DEMANT) Returns On Capital
Oct 31Is Demant (CPH:DEMANT) Using Too Much Debt?
Oct 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price
Oct 01Here's What's Concerning About Demant's (CPH:DEMANT) Returns On Capital
Jul 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Jul 11A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jun 26Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly
Jun 13Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Apr 18Is It Too Late To Consider Buying Demant A/S (CPH:DEMANT)?
Apr 04Are Investors Undervaluing Demant A/S (CPH:DEMANT) By 25%?
Mar 21These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Reasonably Well
Mar 08Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 77% Above Its Share Price
Dec 06Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Nov 22We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
Oct 04Does Demant (CPH:DEMANT) Deserve A Spot On Your Watchlist?
Sep 20Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 95% Above Its Share Price
Sep 07What Is Demant A/S's (CPH:DEMANT) Share Price Doing?
Aug 19Many Would Be Envious Of Demant's (CPH:DEMANT) Excellent Returns On Capital
Jul 18Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly
Jun 22Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate
Jun 09If You Like EPS Growth Then Check Out Demant (CPH:DEMANT) Before It's Too Late
May 28Is Now The Time To Look At Buying Demant A/S (CPH:DEMANT)?
May 16Shareholders Are Optimistic That Demant (CPH:DEMANT) Will Multiply In Value
Apr 09Is Demant (CPH:DEMANT) A Risky Investment?
Mar 16Shareholders Would Not Be Objecting To Demant A/S' (CPH:DEMANT) CEO Compensation And Here's Why
Mar 03Is There An Opportunity With Demant A/S' (CPH:DEMANT) 23% Undervaluation?
Mar 01Should You Be Adding Demant (CPH:DEMANT) To Your Watchlist Today?
Feb 17What Does Demant A/S's (CPH:DEMANT) Share Price Indicate?
Feb 05Capital Investment Trends At Demant (CPH:DEMANT) Look Strong
Jan 05Does Demant (CPH:DEMANT) Have A Healthy Balance Sheet?
Dec 08Estimating The Fair Value Of Demant A/S (CPH:DEMANT)
Nov 13Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Oct 31Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Oct 04These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Safely
Sep 08Is It Time To Consider Buying Demant A/S (CPH:DEMANT)?
Jul 26Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return
Jun 27Is Demant (CPH:DEMANT) Using Too Much Debt?
May 31Estimating The Intrinsic Value Of Demant A/S (CPH:DEMANT)
May 03Should You Investigate Demant A/S (CPH:DEMANT) At kr.305?
Apr 19Investors Could Be Concerned With Demant's (CPH:DEMANT) Returns On Capital
Mar 23Do Its Financials Have Any Role To Play In Driving Demant A/S' (CPH:DEMANT) Stock Up Recently?
Mar 09Is Demant (CPH:DEMANT) A Risky Investment?
Feb 24Are Demant's (CPH:DEMANT) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 11
Is Demant A/S (CPH:DEMANT) Worth kr.221 Based On Its Intrinsic Value?
Jan 30Desglose de ingresos y gastosBeta
Desglose de ingresos y gastos
BetaCómo gana y gasta dinero Demant. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 22,443 | 2,552 | 11,036 | 1,410 |
| 30 Sep 23 | 21,903 | 2,464 | 10,937 | 1,390 |
| 30 Jun 23 | 21,363 | 2,375 | 10,838 | 1,369 |
| 31 Mar 23 | 20,534 | 2,325 | 10,542 | 1,342 |
| 31 Dec 22 | 19,705 | 2,274 | 10,246 | 1,314 |
| 30 Sep 22 | 19,181 | 2,460 | 9,851 | 1,274 |
| 30 Jun 22 | 18,656 | 2,645 | 9,455 | 1,233 |
| 31 Mar 22 | 18,281 | 2,671 | 9,178 | 1,186 |
| 31 Dec 21 | 17,905 | 2,696 | 8,900 | 1,139 |
| 30 Sep 21 | 17,521 | 2,453 | 8,651 | 1,170 |
| 30 Jun 21 | 17,137 | 2,209 | 8,401 | 1,200 |
| 31 Mar 21 | 15,803 | 1,665 | 8,145 | 1,231 |
| 31 Dec 20 | 14,469 | 1,121 | 7,889 | 1,261 |
| 30 Sep 20 | 14,072 | 970 | 7,952 | 1,224 |
| 30 Jun 20 | 13,674 | 818 | 8,014 | 1,186 |
| 31 Mar 20 | 14,310 | 1,140 | 8,138 | 1,153 |
| 31 Dec 19 | 14,946 | 1,462 | 8,261 | 1,120 |
| 30 Sep 19 | 14,728 | 1,579 | 8,068 | 1,093 |
| 30 Jun 19 | 14,510 | 1,695 | 7,874 | 1,066 |
| 31 Mar 19 | 14,224 | 1,759 | 7,593 | 1,030 |
| 31 Dec 18 | 13,937 | 1,823 | 7,312 | 994 |
| 30 Sep 18 | 13,699 | 1,836 | 7,084 | 956 |
| 30 Jun 18 | 13,461 | 1,849 | 6,856 | 918 |
| 31 Mar 18 | 13,325 | 1,802 | 6,809 | 887 |
| 31 Dec 17 | 13,189 | 1,754 | 6,762 | 856 |
| 30 Sep 17 | 12,943 | 1,689 | 6,680 | 831 |
| 30 Jun 17 | 12,697 | 1,624 | 6,597 | 806 |
| 31 Mar 17 | 12,350 | 1,542 | 6,436 | 795 |
| 31 Dec 16 | 12,002 | 1,459 | 6,275 | 784 |
| 30 Sep 16 | 11,717 | 1,429 | 6,068 | 787 |
| 30 Jun 16 | 11,432 | 1,399 | 5,860 | 790 |
| 31 Mar 16 | 11,049 | 1,418 | 5,573 | 777 |
| 31 Dec 15 | 10,665 | 1,436 | 5,285 | 763 |
| 30 Sep 15 | 10,258 | 1,402 | 5,090 | 731 |
| 30 Jun 15 | 9,850 | 1,367 | 4,894 | 699 |
| 31 Mar 15 | 9,598 | 1,347 | 4,693 | 690 |
| 31 Dec 14 | 9,346 | 1,326 | 4,491 | 680 |
| 30 Sep 14 | 9,221 | 1,301 | 4,420 | 673 |
| 30 Jun 14 | 9,095 | 1,275 | 4,348 | 665 |
| 31 Mar 14 | 9,027 | 1,280 | 4,294 | 650 |
| 31 Dec 13 | 8,959 | 1,285 | 4,239 | 634 |
| 30 Sep 13 | 8,830 | 1,235 | 4,098 | 645 |
| 30 Jun 13 | 8,700 | 1,185 | 3,956 | 656 |
Ingresos de calidad: DEMANT tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(11.4%) de DEMANT son inferiores a los del año pasado (11.5%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de DEMANT han crecido un 13.8% al año en los últimos 5 años.
Acelerando crecimiento: El crecimiento de los beneficios de DEMANT en el último año (12.2%) está por debajo de su media de 5 años (13.8% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de DEMANT en el último año (12.2%) superó al de la industria Medical Equipment -0.04%.
Rentabilidad financiera
Alta ROE: Aunque la rentabilidad financiera (27.36%) de DEMANT es alta, esta métrica está sesgada debido a su elevado nivel de endeudamiento.